Datopotamab deruxtecan for the treatment of unresectable NSCLC after failure of first-line therapy.
New Drugs
Novel drugs approved by regulators for human use.
A drug is positioned as new if it:
- offers treatment for a disease for which no specific therapy previously existed
- targets a new therapeutic target
- has a new mechanism of action
- is developed in a new formulation, optimized or improved
- is part of a new combination drug
- belongs to a new class of drug compounds.
Posted inCardiology, New Drugs, Rare/Orphan Diseases, Regulatory
Winrevair: Game-Changer in Pulmonary Arterial Hypertension Treatment
Sotatercept is the first drug that actually modifies PAH.
Posted inMetabolism, New Drugs, Rare/Orphan Diseases, Regulatory
Lenmeldy/Libmeldy: Most Expensive Drug in the World
Atidarsagen autotemcel is a gene therapy for metachromatic leukodystrophy (MLD).
Posted inCardiology, Metabolism, New Drugs, Regulatory
Tryvio: Brand New High Blood Pressure Medication
Aprocitentan for the treatment of resistant arterial hypertension.
Posted inNeuroscience, New Drugs, Rare/Orphan Diseases, Regulatory
Duvyzat: Givinostat for Duchenne Muscular Dystrophy Treatment
Oral givinostat delays the progression of DMD.
Posted inNew Drugs, Oncology, Regulatory
Tevimbra: Immuno-Oncologic Treatment for Esophageal Cancer
Tislelizumab for the treatment of unresectable or metastatic esophageal squamous cell carcinoma.
Posted inAutoimmune Diseases, Metabolism, New Drugs, Regulatory
Awiqli: Basal Insulin Once a Week
Novo Nordisk invented insulin icodec, a very patient-friendly ultra-long-acting insulin.